-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
In -X- _ O
prolonged -X- _ O
hemorrhagic -X- _ O
shock -X- _ O
, -X- _ O
reductions -X- _ O
in -X- _ O
intestinal -X- _ O
mucosal -X- _ O
blood -X- _ O
perfusion -X- _ O
lead -X- _ O
to -X- _ O
mucosal -X- _ O
barrier -X- _ O
damage -X- _ O
and -X- _ O
systemic -X- _ O
inflammation. -X- _ O
Gastrointestinal -X- _ O
failure -X- _ O
in -X- _ O
critically -X- _ O
ill -X- _ O
patients -X- _ O
has -X- _ O
a -X- _ O
poor -X- _ O
prognosis -X- _ O
, -X- _ O
so -X- _ O
early -X- _ O
assessment -X- _ O
of -X- _ O
mucosal -X- _ O
barrier -X- _ O
injury -X- _ O
in -X- _ O
shock -X- _ O
patients -X- _ O
is -X- _ O
clinically -X- _ O
relevant. -X- _ O
Unfortunately -X- _ O
, -X- _ O
there -X- _ O
is -X- _ O
no -X- _ O
serum -X- _ O
marker -X- _ O
that -X- _ O
can -X- _ O
accurately -X- _ O
assess -X- _ O
intestinal -X- _ O
ischemia-reperfusion -X- _ O
injury. -X- _ O
OBJECTIVE -X- _ O
: -X- _ O
The -X- _ O
aim -X- _ O
of -X- _ O
this -X- _ O
study -X- _ O
was -X- _ O
to -X- _ O
assess -X- _ O
if -X- _ O
serum -X- _ B-Intervention
diamine -X- _ I-Intervention
oxidase -X- _ I-Intervention
levels -X- _ I-Intervention
can -X- _ O
reflect -X- _ O
intestinal -X- _ O
mucosal -X- _ O
injury -X- _ O
subsequent -X- _ O
to -X- _ O
prolonged -X- _ O
hemorrhagic -X- _ O
shock. -X- _ O
METHODS -X- _ O
: -X- _ O
Thirty -X- _ B-Patient
New -X- _ I-Patient
Zealand -X- _ I-Patient
white -X- _ I-Patient
rabbits -X- _ I-Patient
were -X- _ O
divided -X- _ O
into -X- _ O
three -X- _ O
groups -X- _ O
: -X- _ O
a -X- _ O
control -X- _ B-Comparison
group -X- _ I-Comparison
, -X- _ O
a -X- _ O
medium -X- _ O
blood -X- _ O
pressure -X- _ O
( -X- _ O
BP -X- _ O
) -X- _ O
group -X- _ O
( -X- _ O
exsanguinated -X- _ O
to -X- _ O
a -X- _ O
shock -X- _ O
BP -X- _ O
of -X- _ O
50 -X- _ O
to -X- _ O
41 -X- _ O
mm -X- _ O
Hg -X- _ O
) -X- _ O
, -X- _ O
and -X- _ O
a -X- _ O
low -X- _ O
BP -X- _ O
group -X- _ O
( -X- _ O
exsanguinated -X- _ O
to -X- _ O
a -X- _ O
shock -X- _ O
blood -X- _ O
pressure -X- _ O
of -X- _ O
40 -X- _ O
to -X- _ O
31 -X- _ O
mm -X- _ O
Hg -X- _ O
) -X- _ O
, -X- _ O
in -X- _ O
which -X- _ O
the -X- _ O
shock -X- _ O
BP -X- _ O
was -X- _ O
sustained -X- _ O
for -X- _ O
180 -X- _ O
min -X- _ O
prior -X- _ O
to -X- _ O
fluid -X- _ O
resuscitation. -X- _ O
RESULTS -X- _ O
: -X- _ O
The -X- _ O
severity -X- _ B-Outcome
of -X- _ I-Outcome
hemorrhagic -X- _ I-Outcome
shock -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
low -X- _ I-Outcome
BP -X- _ I-Outcome
group -X- _ I-Outcome
was -X- _ I-Outcome
significantly -X- _ I-Outcome
greater -X- _ I-Outcome
than -X- _ I-Outcome
that -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
medium -X- _ I-Outcome
BP -X- _ I-Outcome
group -X- _ I-Outcome
according -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
post-resuscitation -X- _ I-Outcome
BP -X- _ I-Outcome
, -X- _ I-Outcome
serum -X- _ I-Outcome
tumor -X- _ I-Outcome
necrosis -X- _ I-Outcome
factor -X- _ I-Outcome
( -X- _ I-Outcome
TNF -X- _ I-Outcome
) -X- _ I-Outcome
-α -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
arterial -X- _ I-Outcome
lactate. -X- _ I-Outcome
Intestinal -X- _ I-Outcome
damage -X- _ I-Outcome
was -X- _ I-Outcome
significantly -X- _ I-Outcome
more -X- _ I-Outcome
severe -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
low -X- _ I-Outcome
BP -X- _ I-Outcome
group -X- _ I-Outcome
according -X- _ I-Outcome
to -X- _ I-Outcome
Chiu’s -X- _ I-Outcome
scoring -X- _ I-Outcome
, -X- _ I-Outcome
claudin-1 -X- _ I-Outcome
, -X- _ I-Outcome
intercellular -X- _ I-Outcome
adhesion -X- _ I-Outcome
molecule -X- _ I-Outcome
( -X- _ I-Outcome
ICAM -X- _ I-Outcome
) -X- _ I-Outcome
-1 -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
myeloperoxidase -X- _ I-Outcome
expression. -X- _ I-Outcome
Serum -X- _ I-Outcome
diamine -X- _ I-Outcome
oxidase -X- _ I-Outcome
was -X- _ I-Outcome
significantly -X- _ I-Outcome
increased -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
low -X- _ I-Outcome
BP -X- _ I-Outcome
group -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
medium -X- _ I-Outcome
BP -X- _ I-Outcome
and -X- _ I-Outcome
control -X- _ I-Outcome
groups -X- _ I-Outcome
and -X- _ I-Outcome
was -X- _ I-Outcome
negatively -X- _ I-Outcome
correlated -X- _ I-Outcome
with -X- _ I-Outcome
shock -X- _ I-Outcome
BP. -X- _ O
CONCLUSION -X- _ O
: -X- _ O
Serum -X- _ B-Outcome
diamine -X- _ I-Outcome
oxidase -X- _ I-Outcome
can -X- _ I-Outcome
be -X- _ I-Outcome
used -X- _ I-Outcome
as -X- _ I-Outcome
a -X- _ I-Outcome
serological -X- _ I-Outcome
marker -X- _ I-Outcome
in -X- _ O
evaluating -X- _ O
intestinal -X- _ O
injury -X- _ O
and -X- _ O
shows -X- _ O
promise -X- _ O
as -X- _ O
an -X- _ O
indicator -X- _ O
of -X- _ O
hemorrhagic -X- _ O
shock -X- _ O
severity -X- _ O
. -X- _ O

